230 related articles for article (PubMed ID: 6277027)
21. Tubular carcinoma of the breast: association with multicentricity, bilaterality, and family history of mammary carcinoma.
Lagios MD; Rose MR; Margolin FR
Am J Clin Pathol; 1980 Jan; 73(1):25-30. PubMed ID: 6243440
[TBL] [Abstract][Full Text] [Related]
22. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
Jolly S; Kestin LL; Goldstein NS; Vicini FA
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
[TBL] [Abstract][Full Text] [Related]
23. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
Tot T
Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
[TBL] [Abstract][Full Text] [Related]
24. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma.
Gamallo C; Palacios J; Suarez A; Pizarro A; Navarro P; Quintanilla M; Cano A
Am J Pathol; 1993 Apr; 142(4):987-93. PubMed ID: 7682767
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women.
Reinier KS; Vacek PM; Geller BM
Breast Cancer Res Treat; 2007 Jul; 103(3):343-8. PubMed ID: 17063272
[TBL] [Abstract][Full Text] [Related]
26. Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment.
Schwartz GF; Patchefsky AS; Finklestein SD; Sohn SH; Prestipino A; Feig SA; Singer JS
Arch Surg; 1989 Jan; 124(1):29-32. PubMed ID: 2535928
[TBL] [Abstract][Full Text] [Related]
27. [Bilateral breast carcinoma].
Kasumi F
Nihon Geka Gakkai Zasshi; 1985 Mar; 86(3):266-79. PubMed ID: 2984536
[TBL] [Abstract][Full Text] [Related]
28. Coexistent lobular carcinoma in situ and intraductal carcinoma in a single lobular-duct unit.
Rosen PP
Am J Surg Pathol; 1980 Jun; 4(3):241-6. PubMed ID: 6249133
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for carcinoma in situ of the breast.
Trentham-Dietz A; Newcomb PA; Storer BE; Remington PL
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):697-703. PubMed ID: 10919740
[TBL] [Abstract][Full Text] [Related]
30. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
31. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
32. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
33. Multicentricity of non-palpable breast cancer.
Schwartz GF; Patchesfsky AS; Feig SA; Shaber GS; Schwartz AB
Cancer; 1980 Jun; 45(12):2913-6. PubMed ID: 6248183
[TBL] [Abstract][Full Text] [Related]
34. Breast magnetic resonance imaging for preoperative locoregional staging.
Hollingsworth AB; Stough RG; O'Dell CA; Brekke CE
Am J Surg; 2008 Sep; 196(3):389-97. PubMed ID: 18436185
[TBL] [Abstract][Full Text] [Related]
35. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.
Wagner PL; Kitabayashi N; Chen YT; Shin SJ
Am J Clin Pathol; 2009 Dec; 132(6):871-6. PubMed ID: 19926578
[TBL] [Abstract][Full Text] [Related]
36. The impact of large sections on the study of in situ and invasive duct carcinoma of the breast.
Foschini MP; Flamminio F; Miglio R; Calò DG; Cucchi MC; Masetti R; Eusebi V
Hum Pathol; 2007 Dec; 38(12):1736-43. PubMed ID: 17714759
[TBL] [Abstract][Full Text] [Related]
37. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
38. Pathobiology of breast cancer--treatment implications.
Vorherr H
Eur J Obstet Gynecol Reprod Biol; 1984 May; 17(2-3):219-35. PubMed ID: 6329835
[TBL] [Abstract][Full Text] [Related]
39. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
[TBL] [Abstract][Full Text] [Related]
40. Hormones and progeny of breast tumor cells.
Schneider HP; Böcker W
Climacteric; 2006 Apr; 9(2):88-107. PubMed ID: 16698656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
